Intramural leiomyoma of uterus
ICD-10 D25.1 is a billable code used to indicate a diagnosis of intramural leiomyoma of uterus.
Intramural leiomyomas, commonly known as uterine fibroids, are benign tumors that develop within the muscular wall of the uterus. These tumors are composed of smooth muscle and fibrous tissue and can vary in size, number, and location. Intramural leiomyomas can cause a range of symptoms, including heavy menstrual bleeding, pelvic pain, and pressure symptoms affecting the bladder or bowel. Diagnosis is typically made through pelvic examination, ultrasound, or MRI. While many women with intramural leiomyomas remain asymptomatic, those experiencing significant symptoms may require treatment options such as medication, uterine artery embolization, or surgical interventions like myomectomy or hysterectomy. Management strategies depend on the size and location of the fibroids, the severity of symptoms, and the patient's reproductive plans. Follow-up care is essential to monitor for changes in symptoms or the development of new fibroids, particularly in women of reproductive age.
Detailed documentation of symptoms, imaging studies, and treatment plans.
Management of symptomatic fibroids, pre-operative assessments, and post-operative follow-ups.
Consideration of patient’s reproductive goals and potential impact of treatment on fertility.
Clear imaging reports indicating the size, location, and characteristics of the leiomyoma.
Ultrasound or MRI evaluations for suspected fibroids.
Accurate imaging interpretation is crucial for proper coding and treatment planning.
Performed for symptomatic intramural leiomyoma causing significant bleeding.
Operative report detailing the indication for surgery and findings.
Obstetricians should document the patient's history and any pre-operative imaging.
Common symptoms include heavy menstrual bleeding, pelvic pain, and pressure symptoms affecting the bladder or bowel. Some women may be asymptomatic.
